Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xiamen Amoytop Biotech CoSHSE:688278 +2.94%75 Interest Coverage is 285.22 as of Mar. 2026, which is 101% above its 10-year median of 142.08. GuruFocus rates SHSE:688278 with a GF Score™ of 75/100 and a GF Value™ of ¥106.91 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 376 Biotechnology companies, Xiamen Amoytop Biotech Co ranks better than 59.57% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Xiamen Amoytop Biotech Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥196 Mil. Xiamen Amoytop Biotech Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-1 Mil.
Xiamen Amoytop Biotech Co's interest coverage for the quarter that ended in Mar. 2026 was 285.22.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Xiamen Amoytop Biotech Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Xiamen Amoytop Biotech Co's Interest Coverage or its related term are showing as below:
SHSE:688278'
s Interest Coverage Range Over the Past 10 Years
Min: 4.51 Med: 142.08 Max: 2135.03
Current: 611.79
SHSE:688278's Interest Coverage is ranked better than 59.57% of 376
companies
in the Biotechnology industry
Industry Median: 106.135
vs SHSE:688278: 611.79
Xiamen Amoytop Biotech Co (SHSE:688278) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Xiamen Amoytop Biotech Co Interest Coverage Related Terms
Xiamen Amoytop Biotech Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
SHSE:688278 vs VRTX, REGN, RVMD: Interest Coverage Comparison
For the Biotechnology subindustry, Xiamen Amoytop Biotech Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xiamen Amoytop Biotech Co Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xiamen Amoytop Biotech Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Xiamen Amoytop Biotech Co's Interest Coverage falls into.
Xiamen Amoytop Biotech Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xiamen Amoytop Biotech Co (SHSE:688278) has a Interest Coverage of 285.22 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Xiamen Amoytop Biotech Co and its competitors. This is 101% above median its historical median of 142.08. Over the past decade, Xiamen Amoytop Biotech Co's Interest Coverage has ranged from 4.51 to 2,135.03. According to the industry distribution chart, Xiamen Amoytop Biotech Co ranks #152 out of 376 companies in the Biotechnology industry, placing it in the top 40.4%.
Is Xiamen Amoytop Biotech Co's Interest Coverage too high?
Xiamen Amoytop Biotech Co's current Interest Coverage of 285.22 is 101% above median its 10-year median of 142.08. Over the past 10 years, this metric has ranged from a low of 4.51 to a high of 2,135.03. The Biotechnology industry median Interest Coverage is 106.14. Xiamen Amoytop Biotech Co's value of 285.22 is 168.7% above this industry median. Based on the distribution chart, Xiamen Amoytop Biotech Co ranks #152 out of 376 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Xiamen Amoytop Biotech Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xiamen Amoytop Biotech Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Xiamen Amoytop Biotech Co ranks #152 out of 376 companies for Interest Coverage. This puts Xiamen Amoytop Biotech Co in the upper half of its industry. The industry median Interest Coverage is 106.14. Xiamen Amoytop Biotech Co's value of 285.22 is 168.7% above this benchmark. Historically, Xiamen Amoytop Biotech Co's own Interest Coverage has ranged from 4.51 to 2,135.03 over the past decade. While the company's 10-year median is 142.08 vs. the industry median of 106.14, Xiamen Amoytop Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.14, based on 376 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xiamen Amoytop Biotech Co's current Interest Coverage of 285.22 is 168.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Xiamen Amoytop Biotech Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xiamen Amoytop Biotech Co's current Interest Coverage is 285.22, which is 101% above median its own 10-year median of 142.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiamen Amoytop Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co (SHSE:688278) is currently considered Possible Value Trap. The stock's GF Value™ is ¥106.91, compared to a current price of ¥60.63 — trading 43.3% below its estimated fair value. The current Interest Coverage is 285.22, which is 101% above median its 10-year median of 142.08 and 168.7% above the Biotechnology industry median of 106.14. Xiamen Amoytop Biotech Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Xiamen Amoytop Biotech Co (SHSE:688278), the current Interest Coverage is 285.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xiamen Amoytop Biotech Co (SHSE:688278) Overvalued in 2026?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co stock appears to be undervalued.
The current stock price of ¥60.63 is trading 43.3% below its estimated GF Value™ of ¥106.91.
GuruFocus considers Xiamen Amoytop Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688278:
Interest Coverage: 285.22 (101% above median its 10-year median of 142.08)
GF Value™: ¥106.91 vs. price of ¥60.63 (43.3% below fair value)
Industry Position: 168.7% above the Biotechnology median (#152 of 376)
No single metric tells the full story. See the SHSE:688278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
75GF Score
Get the complete analysis for SHSE:688278
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688278 has been successfully added to your 
